Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on American Well's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into American Well's regulatory disclosures and financial reporting.
Ross Derek reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Derek Ross received a grant of 14,501 shares of Class A Common Stock in the form of restricted stock units at no cash cost on June 16, 2026. These units vest on the earlier of the day before the first annual stockholder meeting after the grant or the first anniversary of the grant date. After this award, Ross directly holds 71,183 shares.
Goldwasser Rivka reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Rivka Goldwasser received a grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. These units were awarded at no cash cost per share and increase her direct holdings to 105,861 shares following the transaction.
The restricted stock units vest on the earlier of the day immediately preceding the first annual meeting of stockholders after the grant date, or the first anniversary of the grant date, tying the award to both time and the company’s annual meeting cycle.
Schlegel Stephen J. reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Stephen J. Schlegel received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The grant was awarded at no cash cost per share as part of his compensation. Following this award, Schlegel directly holds 69,054 shares of Class A Common Stock. The restricted stock units vest on the earlier of the day immediately before the first annual stockholders’ meeting after the grant date or the first anniversary of the grant date, tying the award to his continued board service.
Jackson Deborah C reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Deborah C. Jackson received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The award was granted at no cash cost per share and is part of her director compensation.
The restricted stock units vest on the earlier of the day immediately before the first annual meeting of stockholders following the grant date or the first anniversary of the grant date. After this grant, Jackson directly holds 53,633 shares of Class A Common Stock.
American Well Corp director Stephen J. Schlegel reported an open-market sale of 9,750 shares of Class A Common Stock at $8.764 per share. The transaction occurred on June 11, 2026 and was executed under a Rule 10b5-1 trading plan.
According to the filing, the plan was adopted on February 17, 2026 and the sale was made to cover tax liabilities from the vesting and settlement of restricted stock units on June 11, 2026. After this sale, Schlegel directly holds 54,553 shares of American Well Corp Class A Common Stock.
American Well Corp’s Chief Financial Officer Mark Hirschhorn reported an automatic sale of 10,761 shares of Class A Common Stock on June 1, 2026 at $9.74 per share. According to the disclosure, this "sell to cover" transaction was executed solely to pay taxes arising from the vesting and settlement of restricted stock units on that date and did not represent a discretionary trade. Following the sale, Hirschhorn directly holds 243,238 shares.
American Well Corp President, International Phyllis Gotlib reported an automatic share sale primarily to cover taxes on vested equity. On June 1, 2026, she sold 3,573 shares of Class A Common Stock at $9.74 per share in an open-market sale designated as a “sell to cover” transaction. After this sale, she held 159,431 shares directly and 114,920 shares indirectly through her husband. The footnote explains that the transaction was executed automatically to satisfy tax liabilities from restricted stock unit vesting and did not represent a discretionary trade.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an open-market sale of 112 shares of Class A Common Stock at $9.74 per share on June 1, 2026. According to the footnote, this automatic “sell to cover” trade was executed solely to pay taxes arising from the vesting and settlement of restricted stock units on that date and did not represent a discretionary trade. Following the sale, McNeice directly holds 10,504 shares of Class A Common Stock.
American Well Corporation reports a Form 144 notice relating to 15,890 shares of Class A Common Stock associated with the vesting of a restricted stock unit grant on 06/01/2026. The filing also records that 10,796 shares were sold on 03/02/2026 by Mark Hirschhorn for $56,603.43.